Background People with schizophrenia are at high risk of suffering from stigma and
internalizing it. Recently, a better understanding of the stigma process has shifted the …

Introduction After extensive research, this study explored whether high‐dose prescriptions
and polypharmacy remain more frequent in Japan than elsewhere. If confirmed, we aimed to …

Background Treatment-refractory psychosis (TRP) is a significant clinical challenge. While
clozapine is frequently effective, alternate or augmentation strategies are often necessary …

Psychopharmacotherapy for patients with schizophrenia in Japan has a long history of
polypharmacy, which is rare worldwide but remains a critical problem. One reason for this is …

Background The influence of socioeconomic deprivation on the cardiovascular health of
patients with psychosis-spectrum disorders (PSD) has not been investigated despite the …

Schizophrenia is a dreaded mental disorder that causes the affected person to believe in
distorted perceptions of reality and affects their quality of life. The pathophysiology of …

We investigated the association between discontinuation due to withdrawal of consent
(DWC) in schizophrenia trials and the use of long-acting injectable antipsychotics (LAI-APs) …

Introduction Recent studies have shown a high frequency of abnormal electrocardiograms in
patients with schizophrenia. The objective of this study was to associate schizophrenia …

A psicofarmacologia é um vasto campo da farmacologia, compreendendo desde o
desenvolvimento dos agentes terapêuticos, passando por diversas etapas préclínicas e …